YOSH AYOLLARDA JINSIY A’ZOLAR XAVFLI O‘SMALARINI ERTA ANIQLASH USULLARI VA AHAMIYATI
Keywords:
Cervical cancer, Endometrial cancer, Ovarian cancer, Ginekologik o‘smalar, 40 yoshli ayollar, Xavfli o‘smalar, Skrining, Pap-test, HPV infeksiyasi, Erta diagnostika, Onkologiya, Profilaktika, Epidemiologiya, Gormonal disbalans, Reproduktiv salomatlik.Abstract
Ushbu maqolada 40 yosh atrofidagi ayollarda uchraydigan asosiy ginekologik xavfli o‘smalar — bachadon bo‘yni saratoni, endometriy (bachadon tanasi) saratoni va tuxumdon saratoni yoritilgan. Maqolada kasalliklarning etiologiyasi, patogenezi, klinik kechishi, zamonaviy diagnostika usullari, xavf omillari va profilaktikasi batafsil ko‘rib chiqilgan. Global va mintaqaviy statistik ma’lumotlar asosida muammoning dolzarbligi asoslab berilgan. Jahon sog‘liqni saqlash tashkiloti (JSST) va GLOBOCAN 2022 ma’lumotlariga ko‘ra, erta aniqlash va skrining dasturlari kasallikdan o‘lim ko‘rsatkichini sezilarli darajada kamaytirishi mumkin.
References
1. Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024.
2. World Health Organization (WHO). Cervical cancer fact sheet. 2025.
3. Global Cancer Observatory (GCO). Cancer Today. International Agency for Research on Cancer; 2024.
4. Zhu B, et al. Global burden of gynaecological cancers in 2022 and projections to 2050. 2024.
5. Oltieva MP, et al. Epidemiology of high-risk HPV in Uzbekistan. 2025.
6. Uzbekistan HPV Information Centre. National cancer profiles and reports on HPV prevalence.
7. International Agency for Research on Cancer (IARC). GLOBOCAN 2022 database: Uzbekistan country profile.
8. Papanikolaou Research Institute. Standard protocols for Pap-test and cervical dysplasia screening.
9. National Center for Health Statistics. Hormonal factors and endometrial cancer risks: Long-term studies on hyperestrogenism.
10. Genetic Research Journal. The role of BRCA1 and BRCA2 mutations in ovarian cancer pathogenesis.
